Differences between intraoperative ultrasound-based dosimetry and postoperative computed tomography-based dosimetry for permanent interstitial prostate brachytherapy

Brachytherapy

Volumn 9, Issue 3, 2010, Pages 219-223

  Ishiyama, Hiromichi ^a   Nakamura, Ryuji ^b   Satoh, Takefumi ^a   Tanji, Susumu ^b   Uemae, Mineko ^c   Baba, Shiro ^a   Hayakawa, Kazushige ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

125I; Brachytherapy; Computed tomography; Dosimetry; Prostate cancer; Ultrasound

Indexed keywords

IODINE 125;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; ECHOGRAPHY; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE; RECTUM; URETHRA;

AGED; AGED, 80 AND OVER; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 77954959954     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.09.007     Document Type: Article

References (17)

1. Battermann J.J., Boon T.A., Moerland M.A. Results of permanent prostate brachytherapy, 13 years of experience at a single institution. Radiother Oncol 2004, 71:23-28.
2. Potters L., Klein E.A., Kattan M.W., et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation. Radiother Oncol 2004, 71:29-33.
3. Ishiyama H., Satoh T., Kitano M., et al. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer. Jpn J Clin Oncol 2008, 38:469-473.
4. Cohen G.N., Amols H.I., Zelefsky M.J., et al. The Anderson nomograms for permanent interstitial prostate implants: A briefing for practitioners. Int J Radiat Oncol Biol Phys 2002, 53:504-511.
5. Rivard M.J., Coursey B.M., Dewerd L.A., et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004, 31:633-674.
6. Nag S., Beyer D., Friedland J., et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 1999, 44:789-799.
7. Nag S., Bice W., DeWyngaert K., et al. The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys 2000, 46:221-230.
8. Ishiyama H., Kitano M., Satoh T., et al. Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer. Radiother Oncol 2006, 78:194-198.
9. Pinkawa M., Asadpour B., Piroth M.D., et al. Rectal dosimetry following prostate brachytherapy with strand seeds-Comparison of transrectal ultrasound intra-operative planning (day 0) and computed tomography-postplanning (day 1 vs. day 30) with special focus on sources placed close to the rectal wall. Radiother Oncol 2009, 91:207-212.
10. Ishiyama H., Kotani S., Satoh T., et al. Needle position during (125)I seed implantation: Accurately recognized by sagittal transrectal ultrasonography?. Radiat Med 2008, 26:512-515.
11. Pfeiffer D., Sutlief S., Feng W., et al. AAPM Task Group 128: Quality assurance tests for prostate brachytherapy ultrasound systems. Med Phys 2008, 35:5471-5489.
12. Stone N., Hong S., Lo Y.C., et al. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Brachytherapy 2003, 2:17-25.
13. Ohashi T., Yorozu A., Toya K., et al. Comparison of intraoperative ultrasound with postimplant computed tomography-Dosimetric values at Day 1 and Day 30 after prostate brachytherapy. Brachytherapy 2007, 6:246-253.
14. Nag S., Shi P., Liu B., et al. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy. Int J Radiat Oncol Biol Phys 2008, 70:311-317.
15. Chauveinc L., Flam T., Solignac S., et al. Prostate cancer brachytherapy: Is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institute Curie/Hospital COCHIN (PARIS) Group. Int J Radiat Oncol Biol Phys 2004, 59:691-695.
16. Igidbashian L., Donath D., Carrier J.F., et al. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy. Int J Radiat Oncol Biol Phys 2008, 72:605-609.
17. Tanaka O., Hayashi S., Sakurai K., et al. Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy. Radiother Oncol 2006, 81:303-308.